TY - JOUR T1 - Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study JF - medRxiv DO - 10.1101/2020.10.04.20205401 SP - 2020.10.04.20205401 AU - Andreas K. Lindner AU - Navina Sarma AU - Luise Marie Rust AU - Theresa Hellmund AU - Svetlana Krasovski-Nikiforovs AU - Mia Wintel AU - Sarah M. Klaes AU - Merle Hoerig AU - Sophia Monert AU - Rolf Schwarzer AU - Anke Edelmann AU - Gabriela Equihua Martinez AU - Frank P. Mockenhaupt AU - Tobias Kurth AU - Joachim Seybold Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/06/2020.10.04.20205401.abstract N2 - Background Living conditions in homeless shelters may facilitate the transmission of COVID-19. Social determinants and pre-existing health conditions place homeless people at increased risk of severe disease. Described outbreaks in homeless shelters resulted in high proportions of infected residents and staff members. In addition to other infection prevention strategies, regular shelter-wide (universal) testing for COVID-19 may be valuable, depending on the level of community transmission and when resources permit.Methods This was a prospective feasibility cohort study to evaluate universal testing for COVID-19 at a homeless shelter with 106 beds in Berlin, Germany. Co-researchers were recruited from the shelter staff. A PCR analysis of saliva or self-collected nasal/oral swab was performed weekly over a period of 3 weeks in July 2020. Acceptability and implementation barriers were analyzed by process evaluation using mixed methods including evaluation sheets, focus group discussion and a structured questionnaire.Results Ninety-three out of 124 (75%) residents were approached to participate in the study. Fifty-one out of the 93 residents (54.8%) gave written informed consent. High retention rates (88.9% – 93.6%) of a weekly respiratory specimen were reached, but repeated collection attempts, as well as assistance were required. A self-collected nasal/oral swab was considered easier and more hygienic to collect than a saliva specimen. No resident was tested positive. Language barriers were the main reason for non-participation. Flexibility of sample collection schedules, the use of video and audio materials, and concise written information were the main recommendations of the co-researchers for future implementation.Conclusion Voluntary universal testing for COVID-19 is feasible in homeless shelters. Universal testing of high-risk facilities will require flexible approaches, considering the level of the community transmission, the available resources, and the local recommendations. Lack of human resources and laboratory capacity may be a major barrier for implementation of universal testing, requiring adapted approaches compared to standard individual testing. Assisted self-collection of specimens and barrier free communication may facilitate implementation in homeless shelters. Program planning must consider homeless people’s needs and life situation, and guarantee confidentiality and autonomy.Competing Interest StatementTK reports to have received honoraria outside of the topic of this study from Total, Newsenselab, Lilly and The BMJ. All other authors have declared no conflicts of interest.Funding StatementThis study was funded by the German Network of University Medicine. The German Network of University Medicine had no role in the design and conduct of the study, analysis, interpretation of data, or in writing of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the Charite-Universitatsmedizin (No.: EA4/141/20).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and/or analyzed during the current study are not publicly available due containing information that could compromise the privacy/consent of the shelter residents but are available from the corresponding author on reasonable request.COVID-19Coronavirus Disease 2019SARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus Type 2RT-PCRReverse Transcription-Polymerase Chain ReactionIQRInterquartile RangeCDCCenters for Disease Control and Prevention ER -